1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

22 Jun 2024
Admin
News Article

YolTech Partners With KACTUS in Greater China

YolTech partners with KACTUS to propel innovation in DNA editing system in Greater China

Overview

YolTech Therapeutics, a clinical-stage biopharmaceutical company specializing in mRNA-LNP delivery for in vivo gene editing therapies, has partnered with KACTUS, a leading developer serving the biopharmaceutical industry, to advance the commercialization of YolTech's proprietary DNA editor, YolCas12, in Greater China. Under this agreement, KACTUS gains exclusive rights for the production and sale of YolCas12.

This strategic partnership will advance gene editing technologies in biomedical applications.

About YolCas12

YolCas12 represents a breakthrough in molecular-level targeted modifications, offering unparalleled accuracy and efficiency.
This technology holds tremendous potential for diverse applications, including gene therapy and biomedical research which has been validated by multiple collaborative companies.
Currently, TolTech has applied this editor to enter the clinical trial stage.

Words from CEO: YolTech

"We are excited to announce this collaboration with KACTUS, which underscores our leadership in genetic innovation,"" said Dr. Yuxuan Wu, founder and CEO of YolTech.
"This milestone reflects our commitment to advancing in vivo gene editing and our dedication to improving patient outcomes.""

Gang Wang, Founder and CEO of KACTUS, added, "" We are excited to integrate YolTech's leading gene editing tools with KACTUS's commercial capabilities, enhancing accessibility to advanced therapies.""

YolTech

YolTech has built a leading high-throughput evolution platform and innovative LNP delivery system.
YolTech possesses a strong capability for novel Cas and base editor discovery, as well as exceptional in-house LNP production capacity for GMP manufacturing.
It holds independent intellectual property rights and core patent protection globally.
The company has created a pipeline of 10 genetic medicines focusing on cardiovascular diseases, metabolic diseases, infectious diseases, as well as more common and rare diseases.
Clinical trial clearance has been received for its leading asset in March 2024.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!